Document Detail

The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
MedLine Citation:
PMID:  8689948     Owner:  NLM     Status:  MEDLINE    
The pharmacokinetics and disposition of valproic acid (VPA) have been assessed in pregnant sheep after both maternal and fetal iv bolus administration. The time course of VPA and 16 of its metabolites was followed in maternal and fetal arterial blood, amniotic fluid, and fetal tracheal fluid for 48 hr after administration. Fetal blood gas, acid-base, metabolic, cardiovascular, and fetal breathing activity parameters were also monitored. The disposition of VPA in maternal serum is best described by a biexponential function with a terminal elimination half-life of 2.13 +/- 0.49 hr and volume of distribution of 0.242 +/- 0.036 liter/kg. VPA transfer to fetal serum and other fetal fluids was rapid after drug administration. There was significant fetal exposure to VPA after maternal dosing (mean AUCinfinityFA/AUCinfinityMA = 0.410 +/- 0.118). Similarly, the disposition of VPA in fetal serum after fetal dosing is best described by a biexponential decay with a terminal elimination half-life of 3.37 +/- 1.37 hr. Once again, VPA transfer to other fluids was rapid. However, unlike basic compounds studied previously, VPA did not accumulate extensively in either amniotic or fetal tracheal fluid. The following metabolites were detected after drug administration in these experiments: (E)- and (Z)-2-ene VPA, (E)- and (Z)-3-ene VPA, 4-ene VPA, 3-keto VPA, 4-keto VPA, 3-OH VPA, 4-OH VPA, 5-OH VPA, and 2-PGA. Both maternal and fetal bolus administration of VPA elicited a significant reduction in fetal breathing movements, which may be attributed to the drug's action on gamma-aminobutyric acid dynamics in the central nervous system (CNS). This suggests that the significant fetal exposure to VPA may produce further CNS-related effects in utero.
J D Gordon; K W Riggs; D W Rurak; E Kwan; C Hall; F S Abbott
Related Documents :
7097468 - Ritodrine concentrations in maternal and fetal serum and amniotic fluid.
9575948 - Development of ingestive behavior.
7064998 - Autosomal mosaicism in amniotic fluid cells from a twin pregnancy.
25400958 - Disseminated cancer in pregnancy: krukenberg tumour.
8347888 - Laparoscopic cholecystectomy and pregnancy.
2361478 - Changes in the glycosylated and nonglycosylated forms of prolactin and growth hormone i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Drug metabolism and disposition: the biological fate of chemicals     Volume:  23     ISSN:  0090-9556     ISO Abbreviation:  Drug Metab. Dispos.     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-08-29     Completed Date:  1996-08-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421550     Medline TA:  Drug Metab Dispos     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1383-9     Citation Subset:  IM    
Faculty of Medicine, University of British Columbia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amniotic Fluid / metabolism
Anticonvulsants / administration & dosage,  pharmacokinetics*
Blood Gas Analysis
Fetus / physiology
Injections, Intravenous
Maternal-Fetal Exchange
Pregnancy, Animal / metabolism*
Valproic Acid / administration & dosage,  pharmacokinetics*
Water-Electrolyte Balance / drug effects
Reg. No./Substance:
0/Anticonvulsants; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines ...
Next Document:  Oxidation of aldehydes catalyzed by pig liver flavin-containing monooxygenase.